Ablative Solutions Completes Enrollment in Pivotal Trial of

April 12, 2023—Ablative Solutions, Inc. announced the completion of patient enrollment in the TARGET BP I study, which is evaluating alcohol-med

Related Keywords

Georgia , United States , Atlanta , David Kandzari , Piedmont Heart Institute In Atlanta , Ablative Solutions Inc , Ablative Solutions , Coprincipal Investigator David Kandzari , Interventional Cardiology , Chief Scientific Officer , Piedmont Heart Institute , Bhtn , Cdn , Hypertension , Renal Denervation , Target Bp , Blood Pressure ,